Menu
Live News EQUITY M impact

Traws Pharma Files DEF 14A

Traws Pharma submits proxy statement to SEC, potentially indicating upcoming shareholder meeting or corporate action.

TRAW

Filed: 2026-05-29 AccNo: 0001104659-26-067945 Size: 2 MB